Vignesh T. Packiam

An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non–muscle-invasive bladder cancer: Interim results

Vignesh T. Packiam, Donald L. Lamm, Daniel A. Barocas et al. · Urologic Oncology Seminars and Original Investigations · 2017 · 243 citations

Medicine, Oncology, Pharmacology +13

Minimally Invasive Liver Resection: Robotic Versus Laparoscopic Left Lateral Sectionectomy

Vignesh T. Packiam, David L. Bartlett, Samer Tohme et al. · Journal of Gastrointestinal Surgery · 2012 · 141 citations

Medicine, Surgery, General Surgery +8

Comparison of Sequential Intravesical Gemcitabine and Docetaxel vs Bacillus Calmette-Guérin for the Treatment of Patients With High-Risk Non–Muscle-Invasive Bladder Cancer

Ian M. McElree, Ryan L. Steinberg, Sarah L. Mott et al. · JAMA Network Open · 2023 · 113 citations · Full text

Medicine, Oncology, Urology +9

Sequential Intravesical Gemcitabine and Docetaxel for bacillus Calmette-Guérin-Naïve High-Risk Nonmuscle-Invasive Bladder Cancer

Ian M. McElree, Ryan L. Steinberg, Alex C. Martin et al. · The Journal of Urology · 2022 · 70 citations

Medicine, Oncology, Pharmacotherapy +11

Utilization and Outcomes of Nephroureterectomy for Upper Tract Urothelial Carcinoma by Surgical Approach

Joseph F. Rodriguez, Vignesh T. Packiam, William R. Boysen et al. · Journal of Endourology · 2017 · 64 citations

Medicine, Surgery, Urology +17